Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Preterm Preeclampsia
NCT02782559Phase 3Withdrawn
- Sponsor
- UTHealth Houston
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia comparing Sildenafil with Placebo (2 arms). Primary endpoint: Duration of pregnancy from diagnosis/randomization until delivery up to 34 weeks. Planned start Jul 2016; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT02782559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782559.